2024-09-24 - Analysis Report
## AbbVie Inc (ABBV) Stock Analysis:

**Company Overview:** AbbVie Inc is a global biopharmaceutical company that develops, manufactures, and markets pharmaceutical products for a range of therapeutic areas. 

**1. Performance vs. S&P 500 (VOO):**

* ABBV has outperformed the S&P 500 (VOO) with a cumulative return of 152.17% compared to VOO's 132.53%. 
* The current performance gap is 19.64%, which is located at 60.86% percentile based on historical data. This means that the current outperformance is relatively strong compared to historical trends.

**2. Recent Price Movement:**

* **Closing Price:** $193.47
* **5-Day Moving Average:** $193.65
* **20-Day Moving Average:** $195.28
* **60-Day Moving Average:** $185.35 

The recent price action suggests a short-term downtrend, as the closing price is slightly below the 5-day and 20-day moving averages. However, the stock is still trading above its 60-day moving average, indicating a potential long-term uptrend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 43.94 
    * The RSI suggests that ABBV is currently in a neutral territory, neither overbought nor oversold.
* **PPO (Percentage Price Oscillator):** -0.46
    * The PPO indicates a short-term bearish trend, as the price is below its moving average.
* **Delta_Previous_Relative_Divergence:** -8.74 
    * This suggests a short-term bearish trend, as the relative divergence has decreased over the past 20 days.
* **Expected Return:** 24.47%
    * This represents a potential 5-year expected return on the stock.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 |
| 2024-04-26 | 2.31 | 2.26 |
| 2024-02-02 | 2.79 | 2.76 |
| 2023-10-27 | 2.95 | 2.86 |
| 2023-07-27 | 2.91 | 2.79 |

* ABBV has consistently exceeded analysts' earnings expectations in recent quarters.
* The latest earnings report, released on 2024-07-25, showed EPS of $2.65, surpassing the expected $2.57. 
* This positive performance suggests continued strong earnings growth and validates the positive outlook for the company.

**5. Summary:**

* ABBV has outperformed the S&P 500 in the long term and has maintained a strong recent performance.
* Current technical indicators suggest a short-term downtrend, but long-term prospects remain positive.
* The company consistently delivers strong earnings, exceeding analyst expectations.

**6. Conclusion:**

ABBV presents a potentially attractive investment opportunity for investors seeking long-term growth. Despite recent short-term weakness, the stock's long-term performance and positive earnings outlook point to continued value creation for shareholders. However, it's important to monitor the stock's short-term price action and key technical indicators to assess potential entry and exit points.